TXMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
TherapeuticsMD, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$1.86−0.04 (-2.11%)
Close on Oct 19, 2026
- Market cap
- $21.66M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
TherapeuticsMD has not reported a dividend
No dividend per share appears in TherapeuticsMD's annual filings since fiscal 2010.